Feasibility and safety of dose-dense docetaxel after conventional epirubicin and cyclophosphamide as adjuvant treatment for early breast cancer patients-Reference-Cited by-同舟云学术

Feasibility and safety of dose-dense docetaxel after conventional epirubicin and cyclophosphamide as adjuvant treatment for early breast cancer patients

Published:2013-10 Issue:5 Volume:22 Page:926-932
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Sanna G.,Pestrin M.,Zafarana E.,Biagioni C.,Cavaciocchi D.,Turner N.,Di Leo A.,Biganzoli L.

Funder

“Sandro Pitigliani” Foundation

AIRC

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference25 articles.

1. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials;Peto;Lancet,2012

2. Adjuvant chemotherapy–yes or no? Prognostic markers in early breast cancer;Piccart-Gebhart;Ann Oncol,2007

3. Adjuvant chemotherapy for breast cancer–30 years later;Levine;N Engl J Med,2006

4. Adjuvant taxanes in the treatment of breast cancer: no longer at the tip of the iceberg;Dang;Clin Breast Cancer,2006

5. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009;Goldhirsch;Ann Oncol,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of anti-tumor (E)-3-X-oxindole via functionalization of C20 nano structure: A DFT approach;Computational and Theoretical Chemistry;2022-08

2. Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study;British Journal of Cancer;2016-03-31

3. A DFT study on the physical adsorption of cyclophosphamide derivatives on the surface of fullerene C60 nanocage;Journal of Molecular Graphics and Modelling;2014-07